Remove FDA Approval Remove Genetic Engineering Remove Genetics
article thumbnail

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use

The Pharma Data

FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S. Professional. MONDAY, Dec.

article thumbnail

How Centralized IBC Review Can Benefit Gene Therapy Research

Advarra

Gene therapy involves the transfer of engineered genetic materials to human research subjects. As of June 2023, 416 Phase III studies are listed, representing a growing pipeline of gene therapy products preparing to undergo consideration for FDA approval.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

It will be six years since the US FDA approval of Kymriah in August this year. Bruce Levine [BL]: We now have six approved CAR-T therapies. That’s not to say that we couldn’t have some approvals coming next year or the year after that for allogeneic therapies. How has the field changed in recent years?

article thumbnail

mRNA Cancer Vaccines and Therapies: An Overview

Advarra

Personalized medicine using genetic resequencing techniques, such as cell and gene therapies, enables researchers to create more customized therapies for combatting cancer. These advancements are part of a larger effort to make cancer research more precise and more effective.

article thumbnail

A history of blood cancer treatment

pharmaphorum

Just over a decade after it was developed by biochemist Nicholas Lyndon, Imatinib received US Food and Drug Administration (FDA) approval in 2001. Over the past few years, the number of treatments approved for blood cancer has skyrocketed. 2002 – Emergence of CAR-T therapy. 2012 – The 100,000 Genomics Project begins.

article thumbnail

Brain Awareness Week 2024: A Spotlight on Brain Health and New Treatments for Neurological Diseases

XTalks

This includes discussions on cutting-edge technologies and methodologies in brain research, such as neuroimaging, genetic engineering and artificial intelligence. Boston Scientific’s Deep Brain Stimulation (DBS) Software received FDA approval last year for the treatment of Parkinson’s disease and essential tremor.

article thumbnail

Colorectal Cancer Awareness Month 2024: Innovations in Treatment

XTalks

For CRC, treatment options that are targeting genetic mutations such as BRAF , KRAS and HER2 have been developed. Gene Editing and CAR T-Cell Therapy Genetic engineering technologies, such as CRISPR-Cas9, are providing newer potential avenues for cancer treatment. Yang Liu and CFO Abid Ansari – Xtalks Life Science Podcast Ep.